STD Diagnostics Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
40468 | Date :
Jan, 2023 | Pages :
182 | Region : Global |
Publisher : Ri
STD Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global STD Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2018-2030.
The key players covered in this study
Abbott
ADI/American Diagnostica
Agilent Technologies
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Sienco
Sysmex
Takara Bio
ThermoFisher
Tosoh
Wako
Zycare/Alere
Market segment by Type, the product can be split into
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing Market segment by Application, split into
Laboratory Testing
Point of Care Testing
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter One: Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by STD Diagnostics Revenue
1.4 Market by Type
1.4.1 Global STD Diagnostics Market Size Growth Rate by Type: 2020 VS 2030
1.4.2 Chlamydia Testing
1.4.3 Syphilis Testing
1.4.4 Gonorrhea Testing
1.4.5 Herpes Simplex Virus Testing
1.4.6 Human Papilloma Virus Testing
1.4.7 Human Immunodeficiency Virus Testing
1.4.8 Chancroid Testing
1.5 Market by Application
1.5.1 Global STD Diagnostics Market Share by Application: 2020 VS 2030
1.5.2 Laboratory Testing
1.5.3 Point of Care Testing
1.6 Study Objectives
1.7 Years Considered
Chapter Two: Global Growth Trends
2.1 Global STD Diagnostics Market Perspective (2018-2030)
2.2 Global STD Diagnostics Growth Trends by Regions
2.2.1 STD Diagnostics Market Size by Regions: 2015 VS 2020 VS 2030
2.2.2 STD Diagnostics Historic Market Share by Regions (2018-2022)
2.2.3 STD Diagnostics Forecasted Market Size by Regions (2023 - 2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter\'s Five Forces Analysis
2.3.5 STD Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key STD Diagnostics Players (Opinion Leaders)
Chapter Three: Competition Landscape by Key Players
3.1 Global Top STD Diagnostics Players by Market Size
3.1.1 Global Top STD Diagnostics Players by Revenue (2018-2022)
3.1.2 Global STD Diagnostics Revenue Market Share by Players (2018-2022)
3.1.3 Global STD Diagnostics Market Share by Company Type (Tier 1, Tier Chapter Two: and Tier 3)
3.2 Global STD Diagnostics Market Concentration Ratio
3.2.1 Global STD Diagnostics Market Concentration Ratio (CRChapter Five: and HHI)
3.2.2 Global Top Chapter Ten: and Top 5 Companies by STD Diagnostics Revenue in 2019
3.3 STD Diagnostics Key Players Head office and Area Served
3.4 Key Players STD Diagnostics Product Solution and Service
3.5 Date of Enter into STD Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
Chapter Four: Market Size by Type (2018-2030)
4.1 Global STD Diagnostics Historic Market Size by Type (2018-2022)
4.2 Global STD Diagnostics Forecasted Market Size by Type (2023 - 2030)
Chapter Five: Market Size by Application (2018-2030)
5.1 Global STD Diagnostics Market Size by Application (2018-2022)
5.2 Global STD Diagnostics Forecasted Market Size by Application (2023 - 2030)
Chapter Six: North America
6.1 North America STD Diagnostics Market Size (2018-2022)
6.2 STD Diagnostics Key Players in North America (2019-2020)
6.3 North America STD Diagnostics Market Size by Type (2018-2022)
6.4 North America STD Diagnostics Market Size by Application (2018-2022)
Chapter Seven: Europe
7.1 Europe STD Diagnostics Market Size (2018-2022)
7.2 STD Diagnostics Key Players in Europe (2019-2020)
7.3 Europe STD Diagnostics Market Size by Type (2018-2022)
7.4 Europe STD Diagnostics Market Size by Application (2018-2022)
Chapter Eight: China
8.1 China STD Diagnostics Market Size (2018-2022)
8.2 STD Diagnostics Key Players in China (2019-2020)
8.3 China STD Diagnostics Market Size by Type (2018-2022)
8.4 China STD Diagnostics Market Size by Application (2018-2022)
Chapter Nine: Japan
9.1 Japan STD Diagnostics Market Size (2018-2022)
9.2 STD Diagnostics Key Players in Japan (2019-2020)
9.3 Japan STD Diagnostics Market Size by Type (2018-2022)
9.4 Japan STD Diagnostics Market Size by Application (2018-2022)
Chapter Ten: Southeast Asia
10.1 Southeast Asia STD Diagnostics Market Size (2018-2022)
10.2 STD Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia STD Diagnostics Market Size by Type (2018-2022)
10.4 Southeast Asia STD Diagnostics Market Size by Application (2018-2022)
Chapter Eleven: India
11.1 India STD Diagnostics Market Size (2018-2022)
11.2 STD Diagnostics Key Players in India (2019-2020)
11.3 India STD Diagnostics Market Size by Type (2018-2022)
11.4 India STD Diagnostics Market Size by Application (2018-2022)
Chapter Twelve: Central & South America
12.1 Central & South America STD Diagnostics Market Size (2018-2022)
12.2 STD Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America STD Diagnostics Market Size by Type (2018-2022)
12.4 Central & South America STD Diagnostics Market Size by Application (2018-2022)
Chapter Thirteen: Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott STD Diagnostics Introduction
13.1.4 Abbott Revenue in STD Diagnostics Business (2018-2022))
13.1.5 Abbott Recent Development
13.2 ADI/American Diagnostica
13.2.1 ADI/American Diagnostica Company Details
13.2.2 ADI/American Diagnostica Business Overview
13.2.3 ADI/American Diagnostica STD Diagnostics Introduction
13.2.4 ADI/American Diagnostica Revenue in STD Diagnostics Business (2018-2022)
13.2.5 ADI/American Diagnostica Recent Development
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Details
13.3.2 Agilent Technologies Business Overview
13.3.3 Agilent Technologies STD Diagnostics Introduction
13.3.4 Agilent Technologies Revenue in STD Diagnostics Business (2018-2022)
13.3.5 Agilent Technologies Recent Development
13.4 Alere/Biosite/Inverness
13.4.1 Alere/Biosite/Inverness Company Details
13.4.2 Alere/Biosite/Inverness Business Overview
13.4.3 Alere/Biosite/Inverness STD Diagnostics Introduction
13.4.4 Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2018-2022)
13.4.5 Alere/Biosite/Inverness Recent Development
13.5 Axis-Shield
13.5.1 Axis-Shield Company Details
13.5.2 Axis-Shield Business Overview
13.5.3 Axis-Shield STD Diagnostics Introduction
13.5.4 Axis-Shield Revenue in STD Diagnostics Business (2018-2022)
13.5.5 Axis-Shield Recent Development
13.6 Beckman Coulter/Danaher
13.6.1 Beckman Coulter/Danaher Company Details
13.6.2 Beckman Coulter/Danaher Business Overview
13.6.3 Beckman Coulter/Danaher STD Diagnostics Introduction
13.6.4 Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2018-2022)
13.6.5 Beckman Coulter/Danaher Recent Development
13.7 Becton Dickinson
13.7.1 Becton Dickinson Company Details
13.7.2 Becton Dickinson Business Overview
13.7.3 Becton Dickinson STD Diagnostics Introduction
13.7.4 Becton Dickinson Revenue in STD Diagnostics Business (2018-2022)
13.7.5 Becton Dickinson Recent Development
13.8 Bio/Data
13.8.1 Bio/Data Company Details
13.8.2 Bio/Data Business Overview
13.8.3 Bio/Data STD Diagnostics Introduction
13.8.4 Bio/Data Revenue in STD Diagnostics Business (2018-2022)
13.8.5 Bio/Data Recent Development
13.9 Decode Genetics
13.9.1 Decode Genetics Company Details
13.9.2 Decode Genetics Business Overview
13.9.3 Decode Genetics STD Diagnostics Introduction
13.9.4 Decode Genetics Revenue in STD Diagnostics Business (2018-2022)
13.9.5 Decode Genetics Recent Development
13.10 Diadexus
13.10.1 Diadexus Company Details
13.10.2 Diadexus Business Overview
13.10.3 Diadexus STD Diagnostics Introduction
13.10.4 Diadexus Revenue in STD Diagnostics Business (2018-2022)
13.10.5 Diadexus Recent Development
13.11 Diagnocure
10.11.1 Diagnocure Company Details
10.11.2 Diagnocure Business Overview
10.11.3 Diagnocure STD Diagnostics Introduction
10.11.4 Diagnocure Revenue in STD Diagnostics Business (2018-2022)
10.11.5 Diagnocure Recent Development
13.12 Diagnostica Stago/Trinity Biotech
10.12.1 Diagnostica Stago/Trinity Biotech Company Details
10.12.2 Diagnostica Stago/Trinity Biotech Business Overview
10.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Introduction
10.12.4 Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2018-2022)
10.12.5 Diagnostica Stago/Trinity Biotech Recent Development
13.13 Diamedix
10.13.1 Diamedix Company Details
10.13.2 Diamedix Business Overview
10.13.3 Diamedix STD Diagnostics Introduction
10.13.4 Diamedix Revenue in STD Diagnostics Business (2018-2022)
10.13.5 Diamedix Recent Development
13.14 Polymedco
10.14.1 Polymedco Company Details
10.14.2 Polymedco Business Overview
10.14.3 Polymedco STD Diagnostics Introduction
10.14.4 Polymedco Revenue in STD Diagnostics Business (2018-2022)
10.14.5 Polymedco Recent Development
13.15 Qiagen
10.15.1 Qiagen Company Details
10.15.2 Qiagen Business Overview
10.15.3 Qiagen STD Diagnostics Introduction
10.15.4 Qiagen Revenue in STD Diagnostics Business (2018-2022)
10.15.5 Qiagen Recent Development
13.16 Roche
10.16.1 Roche Company Details
10.16.2 Roche Business Overview
10.16.3 Roche STD Diagnostics Introduction
10.16.4 Roche Revenue in STD Diagnostics Business (2018-2022)
10.16.5 Roche Recent Development
13.17 SDIX
10.17.1 SDIX Company Details
10.17.2 SDIX Business Overview
10.17.3 SDIX STD Diagnostics Introduction
10.17.4 SDIX Revenue in STD Diagnostics Business (2018-2022)
10.17.5 SDIX Recent Development
13.18 Sequenom
10.18.1 Sequenom Company Details
10.18.2 Sequenom Business Overview
10.18.3 Sequenom STD Diagnostics Introduction
10.18.4 Sequenom Revenue in STD Diagnostics Business (2018-2022)
10.18.5 Sequenom Recent Development
13.19 Siemens
10.19.1 Siemens Company Details
10.19.2 Siemens Business Overview
10.19.3 Siemens STD Diagnostics Introduction
10.19.4 Siemens Revenue in STD Diagnostics Business (2018-2022)
10.19.5 Siemens Recent Development
13.20 Sienco
10.20.1 Sienco Company Details
10.20.2 Sienco Business Overview
10.20.3 Sienco STD Diagnostics Introduction
10.20.4 Sienco Revenue in STD Diagnostics Business (2018-2022)
10.20.5 Sienco Recent Development
13.21 Sysmex
10.21.1 Sysmex Company Details
10.21.2 Sysmex Business Overview
10.21.3 Sysmex STD Diagnostics Introduction
10.21.4 Sysmex Revenue in STD Diagnostics Business (2018-2022)
10.21.5 Sysmex Recent Development
13.22 Takara Bio
10.22.1 Takara Bio Company Details
10.22.2 Takara Bio Business Overview
10.22.3 Takara Bio STD Diagnostics Introduction
10.22.4 Takara Bio Revenue in STD Diagnostics Business (2018-2022)
10.22.5 Takara Bio Recent Development
13.23 ThermoFisher
10.23.1 ThermoFisher Company Details
10.23.2 ThermoFisher Business Overview
10.23.3 ThermoFisher STD Diagnostics Introduction
10.23.4 ThermoFisher Revenue in STD Diagnostics Business (2018-2022)
10.23.5 ThermoFisher Recent Development
13.24 Tosoh
10.24.1 Tosoh Company Details
10.24.2 Tosoh Business Overview
10.24.3 Tosoh STD Diagnostics Introduction
10.24.4 Tosoh Revenue in STD Diagnostics Business (2018-2022)
10.24.5 Tosoh Recent Development
13.25 Wako
10.25.1 Wako Company Details
10.25.2 Wako Business Overview
10.25.3 Wako STD Diagnostics Introduction
10.25.4 Wako Revenue in STD Diagnostics Business (2018-2022)
10.25.5 Wako Recent Development
13.26 Zycare/Alere
10.26.1 Zycare/Alere Company Details
10.26.2 Zycare/Alere Business Overview
10.26.3 Zycare/Alere STD Diagnostics Introduction
10.26.4 Zycare/Alere Revenue in STD Diagnostics Business (2018-2022)
10.26.5 Zycare/Alere Recent Development
Chapter Fourteen: Analysts Viewpoints/Conclusions
Chapter Fifteen: Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.